TY - JOUR
T1 - Patient-reported outcome: results of the multicenter German post-market study
AU - Hasselbacher, Katrin
AU - Hofauer, B.
AU - Maurer, J. T.
AU - Heiser, C.
AU - Steffen, A.
AU - Sommer, J. U.
N1 - Funding Information:
Financial disclosure This study is sponsored by Inspire Medical Systems, Inc.
Publisher Copyright:
© 2018, Springer-Verlag GmbH Germany, part of Springer Nature.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Purpose: Upper airway stimulation (UAS) is an alternative second-line treatment option for patients with obstructive sleep apnea (OSA). In our substudy of a previous multicentre study of patients implanted with UAS, we focused on patient-related outcomes like Epworth Sleepiness Scale (ESS), the Functional Outcomes of Sleep Questionnaire (FOSQ), snoring and personal satisfaction 6 and 12 months after the implantation. Methods: 60 patients, who were initially non-adherent to CPAP and implanted with UAS, were included in a prospective multicentre study. Data were collected preoperative, 6 and 12 months after implantation regarding FOSQ, ESS, snoring, and their experience with the UAS device. Results: Besides relevant Apnoea–Hypopnea Index (AHI) reduction, we saw significant improvements in ESS (p < 0.001), FOSQ (p < 0.001) and snoring under UAS therapy. A strong correlation between AHI results postoperative and the personal satisfaction of the patients after implantation was found as well as between usage results and AHI compared to the preoperative results. Conclusion: The more the patients benefit from UAS according to their self-reported outcome, the higher is the therapy use.
AB - Purpose: Upper airway stimulation (UAS) is an alternative second-line treatment option for patients with obstructive sleep apnea (OSA). In our substudy of a previous multicentre study of patients implanted with UAS, we focused on patient-related outcomes like Epworth Sleepiness Scale (ESS), the Functional Outcomes of Sleep Questionnaire (FOSQ), snoring and personal satisfaction 6 and 12 months after the implantation. Methods: 60 patients, who were initially non-adherent to CPAP and implanted with UAS, were included in a prospective multicentre study. Data were collected preoperative, 6 and 12 months after implantation regarding FOSQ, ESS, snoring, and their experience with the UAS device. Results: Besides relevant Apnoea–Hypopnea Index (AHI) reduction, we saw significant improvements in ESS (p < 0.001), FOSQ (p < 0.001) and snoring under UAS therapy. A strong correlation between AHI results postoperative and the personal satisfaction of the patients after implantation was found as well as between usage results and AHI compared to the preoperative results. Conclusion: The more the patients benefit from UAS according to their self-reported outcome, the higher is the therapy use.
UR - http://www.scopus.com/inward/record.url?scp=85047664988&partnerID=8YFLogxK
U2 - 10.1007/s00405-018-5017-1
DO - 10.1007/s00405-018-5017-1
M3 - Journal articles
C2 - 29808422
AN - SCOPUS:85047664988
SN - 0937-4477
VL - 275
SP - 1913
EP - 1919
JO - European Archives of Oto-Rhino-Laryngology
JF - European Archives of Oto-Rhino-Laryngology
IS - 7
ER -